Top Markets
Coin of the day
Devonian Health Group Inc. Devonian Health Group Inc.

Devonian Health Group Inc.

DVHGF
Rangering i aksjer #29820
Devonian Health Group Inc. specializes in the creation of botanical-based... Devonian Health Group Inc. specializes in the creation of botanical-based pharmaceutical drugs. Its leading product candidate, Thykamine, is currently undergoing Phase IIa clinical trials to treat conditions such as ulcerative colitis and atopic dermatitis. The company's development pipeline also includes Pantoprazole Magnesium for addressing gastric or duodenal ulcers, Cleo-35 targeting hormonal acne in women, and a range of value-added dermo-cosmetic products. Beyond its own development efforts, Devonian acquires licenses for and distributes various pharmaceutical and health products. Furthermore, the company has established a strategic partnership with CannTx Life Sciences Inc. to collaborate on the development of cannabinoid-based pharmaceutical drugs. Devonian Health Group Inc. was founded in 2015 and is based in Québec, Canada.
Aksjekurs
$7.00
Sist synkronisert: 2026-08-17
Markedsverdi
$19.47M
Endring (1 dag)
0.00%
Endring (1 år)
-35.19%
Land
CA
Handel Devonian Health Group Inc. (DVHGF)

Kategori

Historikk for aksjesplitt for Devonian Health Group Inc. (DVHGF)
Aksjen Devonian Health Group Inc. (symbol: DVHGF) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 19, 2026.
Én DVHGF-aksje kjøpt før Aug 19, 2026 tilsvarer i dag 0 DVHGF-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
KR